Gain insight into the legal and regulatory landscape of off-label information dissemination with an overview of the FDA, OIG, US Attorney’s Office and individual state rules
Review the difference between scientific exchange of information versus promotion
Minimize risk in the activities of sales representatives, medical science liaisons, marketers and others who engage in medical communications
Understand the challenges of non-traditional media and the corresponding rules of promotion
Analyze case studies of compliant and noncompliant off-label information communication
Examine the situations in which off-label information sharing is acceptable and how to engage most effectively